ORGANOGENESIS HOLDINGS INC.
ORGO · Healthcare · $332.6M mkt cap · FY2025 filings · Shallow moat ·
Doesn't clear the bar
The four filters
Median gross margin 74.2% over 9y, very stable.
Median ROIC 3.4%, above the 9% hurdle in 33% of years.
Net cash position — no leverage risk.
Owner earnings trend unclear, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- $15.5M
- Est. intrinsic value / share
- $1.36
- Recent price
- $2.62
- Discount to value
- 93% above value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
Fundamentals
There's no normalized fundamentals series for ORGO yet — it appears once ingest has processed its filings.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — ORGO has read Shallow moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#86 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #84PGNY Progyny, Inc.57.6 out of 100, Shallow moatShallow moat
- #85DCTH DELCATH SYSTEMS, INC.57.1 out of 100, Shallow moatShallow moat
- #87TRMB TRIMBLE INC.56.8 out of 100, Shallow moatShallow moat
- #88TMO THERMO FISHER SCIENTIFIC INC.56.7 out of 100, Shallow moatShallow moat
Compare ORGO with its nearest peers →All Healthcare companies on the Index →
Common questions about ORGO
- Does ORGANOGENESIS HOLDINGS INC. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores ORGANOGENESIS HOLDINGS INC. (ORGO) 57.1 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 96, returns on capital 12, balance-sheet safety 100, capital discipline 24.
- Is ORGO stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $1.36 per share versus a recent price of $2.62 — 93% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has ORGO's Moat Score changed over time?
- The record logs 2 readings since Jul 17, 2026; the latest reads 57.1 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.